Drugs.com
AUGUST 18, 2024
SUNDAY, Aug. 18, 2024 -- As kids head back to school this fall, there is probably one item many parents haven't thought to put on the to-do list: dental checkups.But they should make sure their children's teeth are in good shape, said Dr. Natasha.
Chemical Biology and Drug Design
AUGUST 18, 2024
The present work systematically gives a comprehensive review in current developments of benzimidazole–oxadiazole hybrid compounds in the whole range of medicinal chemistry and the perspectives that they hold for future research. ABSTRACT To increase the success rate of drug discovery, one practical strategy is to begin molecular hybridisation. The presence of two or more pharmacophores in a single unit leads to a pharmacological potency greater than the sum of each individual moiety's potency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
AUGUST 18, 2024
By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — In 1997, Congress wisely amended the Federal Food, Drug, and Cosmetic Act (FDCA) by adding Section 513(f)(2) to establish the De Novo process. The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use.
ProRelix Research
AUGUST 18, 2024
Although time, speed, and operational constraints have long plagued the progress of clinical trials, another factor that remains important and has been gaining prime importance as the centre of clinical […] The post Putting Patients First: The Shift Towards Patient-Centric Clinical Trials appeared first on ProRelix Research.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Perficient: Drug Development
AUGUST 18, 2024
What Is a Salesforce Approval Process An approval process in Salesforce is a set of steps that automate how records are approved in your organization. It specifies the actions to take when records are submitted for approval, who must approve them, and what happens after approval or rejection. This process ensures that important business decisions and changes to records are reviewed and authorized by the right people consistently and efficiently.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drug Patent Watch
AUGUST 18, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Drug Patent Watch
AUGUST 18, 2024
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA. It is available from one supplier.
Expert insights. Personalized for you.
147 
Let's personalize your content